Wockhardt LimitedNSE: WOCKPHARMA

Press Release Mar 16 2022

· Issued by Wockhardt Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-16-2022-6

Wockhardt Limited has informed the Exchange about press release dated 16-Mar-2022 titled National Institutes of Health (NIH), USA to conduct human Phase 1 trial of Wockhardt���s novel once-a-day MDR Gram-negative antibiotic WCK 6777

View Attachment

6ix hasn’t read this filing yet.

Wockhardt Limited on 6ix

Earlier from Wockhardt

Later from Wockhardt

All Wockhardt news releases